Sevoflurane and desflurane in ischemia-reperfusion injury: Direct and remote organ protection from experimental to clinical evidence
Ischemia-reperfusion (I/R) injury is not confined to ischemic tissue.Oxidative stress, cytokine release, endothelial activation, and apoptosis may also damage organs that were not directly exposed to ischemia.Sevoflurane and desflurane reproduce several components of ischemic preconditioning through mitochondrial ATP-sensitive potassium channel activation, antioxidant signaling, suppression of inflammatory pathways, and reduced apoptosis.This narrative minireview draws on heterogeneous experimental studies and limited clinical evidence.It addresses two questions that are often merged: Whether these agents protect the ischemic organ itself and whether they protect an organ injured remotely after ischemia elsewhere.Six experimental studies were identified in remote injury models, three with each agent, and all six examined the lung.Remote renal and cardiac outcomes were each assessed in only one study, and no studies of remote hepatic or cerebral injury were identified.Only one of the six studies tested a pathway through inhibition.Direct organ-specific evidence is far more extensive for sevoflurane, with pathway testing through inhibition, knockdown, or knockout in the liver, kidney, brain, and lung.Fewer studies have examined desflurane.Several pathways were tested through intervention, but most findings derive from individual studies.Where the two agents have been compared under identical conditions, results diverge: Desflurane produced more reactive oxygen species and greater mitochondrial uncoupling in isolated myocytes and reduced infarct size more than sevoflurane in rabbit myocardium, while a proteomic comparison found no distinguishing pattern.Clinical findings mainly concern biomarkers and intraoperative events; isolated differences in acute kidney injury and prolonged intensive care unit stay have not established a consistent patient-centered benefit.The experimental evidence supports a remote pulmonary effect for both agents but does not yet support a general claim of remote multi-organ protection by either.
Authors
- Necmiye Şengel (ORCID: https://orcid.org/0000-0001-8591-3658)
- Mustafa Arslan (ORCID: https://orcid.org/0000-0003-4882-5063)
Institutions
- Gazi University (TR)
Publication Details
- Journal
- World Journal of Experimental Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5493/wjem.127933
- Primary Topic
- Cardiac Ischemia and Reperfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00